Free Trial
CVE:AQS

Aequus Pharmaceuticals (AQS) Stock Price, News & Analysis

Aequus Pharmaceuticals logo
C$0.0050 -0.01 (-50.00%)
(As of 12/17/2024)

About Aequus Pharmaceuticals Stock (CVE:AQS)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.02
52-Week Range
C$0.01
C$0.04
Volume
20,000 shs
Average Volume
162,018 shs
Market Capitalization
C$663,150.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Receive AQS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AQS Stock News Headlines

Aequus Pharmaceuticals Reports Revenue Growth Amid Restructuring
Aequus Pharmaceuticals Inc. (AQSZF)
The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
Aequus Pharmaceuticals Inc (AQS)
AQS:CA Aequus Pharmaceuticals Inc.
See More Headlines

AQS Stock Analysis - Frequently Asked Questions

Aequus Pharmaceuticals' stock was trading at C$0.03 at the beginning of the year. Since then, AQS shares have decreased by 80.0% and is now trading at C$0.01.
View the best growth stocks for 2024 here
.

Shares of AQS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aequus Pharmaceuticals investors own include GrowLife (PHOT), Unrivaled Brands (TRTC), Acorn Energy (ACFN), Crown Castle (CCI), LiCo Energy Metals (LIC), Marijuana Company of America (MCOA) and Rogers (ROG).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
C$-2,860,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.17 million
Cash Flow
C$0.00 per share
Book Value
C($0.04) per share

Miscellaneous

Free Float
N/A
Market Cap
C$663,150.00
Optionable
Not Optionable
Beta
-0.02
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (CVE:AQS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners